CMR — Center for Molecular Research
Iodine-131
Art. N°
Hover to zoom · click to enlarge
Radionuclides
Diagnosis and treatment of the thyroid gland: assessing functional state, thyroid gland scans and scintigraphy for various conditions including thyroid dysfunction and well-differentiated thyroid cancer with metastases. For therapeutic purposes, used in treating hyperthyroidism and metastases of thyroid cancer.
- Grade
- Non-carrier added radionuclide; GMP product; tested for sterility and bacterial endotoxins
- Half-life
- 8.02 days
- Appearance
- Transparent, colourless liquid
- Chemical form
- 131I in 0.1M NaOH solution | 131I, carrier free, in 0.05M NaOH solution containing 0.001M Na2S2O3
- Specific activity
- > 6.5 Ci/mg
- Radiochemical purity
- >= 95% | >= 98%
- Radioactive concentration
- >= 2000.0 mCi/ml
